Vorkommen von Antikörpern gegen das bovine Immunschwächevirus bei Rindern in Bayern

Maren Bartels; Katrin Hartmann; L. Scobie; O. Jarrett; W. Klee

doi:10.1055/s-0038-1622979

Tierärztliche Praxis Ausgabe G: Großtiere / Nutztiere, Table of Contents

Tierarztl Prax Ausg G Grosstiere Nutztiere 2003; 31(05): 248-253
DOI: 10.1055/s-0038-1622979

Wiederkäuer

Schattauer GmbH

Vorkommen von Antikörpern gegen das bovine Immunschwächevirus bei Rindern in Bayern

Presence of antibodies against bovine immunodeficiency virus in Bavarian cattle

Authors

Maren Bartels

¹Aus der II. Medizinischen Tierklinik (Lehrstuhl für Innere Medizin und Chirurgie der Wiederkäuer, Vorstand Prof. Dr. W. Klee) der Ludwig-Maximilians-Universität München
Katrin Hartmann

²Department of Small Animal Medicine, College of Veterinary Medicine, University of Georgia, USA
L. Scobie

³Department of Veterinary Pathology, University of Glasgow, UK
O. Jarrett

³Department of Veterinary Pathology, University of Glasgow, UK
W. Klee

¹Aus der II. Medizinischen Tierklinik (Lehrstuhl für Innere Medizin und Chirurgie der Wiederkäuer, Vorstand Prof. Dr. W. Klee) der Ludwig-Maximilians-Universität München

Abstract

Zusammenfassung

Im Rahmen einer epidemiologischen Untersuchung zur Infektion mit dem bovinen Immunschwächevirus (BIV) bei Rindern in Oberbayern erfolgten zwei Studien, in denen Serum mittels indirektem ELISA auf BIV-Antikörper untersucht wurde. Die ELISA-Ergebnisse der BIV-positiven Tiere der Studie I wurden mittels Western Blot bestätigt. In Studie I wurde Blut von 173 ungezielt ausgewählten Rinderpatienten der II. Medizinischen Tierklinik der Ludwig-Maximilians-Universität München untersucht. Von diesen waren acht Tiere BIV-infiziert. Das entspricht einer Prävalenz von 4,6%. Alle positiven Tiere waren über zwei Monate alt. In Studie II wurden 550 Kühe aus 11 oberbayerischen landwirtschaftlichen Betrieben untersucht. Hiervon waren 11 Tiere BIVAntikör-perpositiv. Dies entspricht einer Prävalenz von 2,0%. Die positiven Tiere stammten aus fünf Betrieben mit Boxenlaufstallhaltung. Kein Tier aus Betrieben mit Anbindehaltung war positiv. In Studie II lag das Durchschnittsalter der Kühe aus den Betrieben ohne BIV-infizierte Tiere signifikant höher als in den Betrieben mit BIV-infizierten Tieren. Die Prävalenz von BIV-Antikörpern war zwar unter den kranken Probanden aus Studie I signifikant höher als bei den klinisch unauffälligen Rindern der Studie II, die pathogene Bedeutung des BIV erscheint jedoch fraglich.

Summary

In this study, an epidemiological survey on bovine immunodeficiency virus (BIV) infection in Bavaria was performed. The survey was separated into two studies, in which serum was tested for the presence of antibodies against BIV using an indirect ELISA. The BIV ELISA results of the positive animals from the first study were confirmed by Western blot. In study I, blood of 173 cattle suffering from various illnesses was tested, that had been referred to the II. Medical Animal Clinic of the University of Munich. Of these 173 patients, eight were positive, which corresponds to a prevalence of 4.6%. All positive animals were older than two months. In study II, a total of 550 cows from 11 different farms were investigated. Eleven were identified as BIV antibody-positive, which is 2.0% of the investigated population. All positive animals originated from five farms with loose housing. No positive animals were found in farms with tiestalls. In study II, the average age of the cattle was significantly higher in farms without BIV-antibody-positive animals than in farms with BIV-antibody-positive animals. Even though prevalence of BIV antibodies was significantly higher among sick patients (study I) than in healthy animals (study II), the importance of BIV as pathogenic agent remains unclear.

Schlüsselwörter

bovines Inmmunschwächevirus - BIV - Antikörper - Prävalenz - Rind

Keywords

Bovine immunodeficiency virus - BIV - Antibodies - Prevalence - Cattle

Full Text

References

Literatur
1 Cavirani S, Donofrio G, Chiocco D, Foni E, Martelli P, Allegri G, Cabassi CS, DeIaco B, Flammini CF. Seroprevalence to bovine immunodeficiency virus and lack of association with leukocyte counts in Italian dairy cattle. Prev Vet Med 1998; 37: 147-57.
2 Dreyfuss ML, Fawzi WW. Micronutrients and vertical transmission of HIV-1. Am J Clin Nutr 2002; 75: 959-70.
3 Evans AS. Causation and disease: The Henle-Koch postulates revisited. Yale J Biol Med 1976; 49: 175-95.
4 Gonda MA, Braun MJ, Carter SG, Kost TA, Bess Jr JW, Arthur LO, VanDerMaaten MA. Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus. Nature 1987; 330: 388-91.
5 Gonda MA, Luther DG, Fong SE, Tobin GJ. Bovine immunodeficiency virus: molecular biology and virus-host interactions. Vir Res 1994; 32: 155-81.
6 Hirai N, Kabeya H, Ohashi K, Sugimoto C, Onuma M. Detection of antibodies against bovine immunodeficiency-like virus in dairy cattle in Hokkaido. J Vet Med Sci 1996; 58: 455-7.
7 Horzinek M, Keldermans L, Stuurman T, Black J, Herrewegh A, Sillekens P, Koolen M. Bovine immunodeficiency virus: immunochemical characterization and serological survey. J Gen Virol 1991; 72: 2923-8.
8 McNab WB, Jacobs RM, Smith HE. A serological survey for bovine immunodeficiency-like virus in Ontario dairy cattle and associations between test results, production records and management practices. Can J Vet Res 1994; 58: 36-41.
9 Muluneh A. Seroprevalence of bovine immunodeficiency-virus (BIV) antibodies in the cattle population in Germany. Zentralbl Veterinärmed [B] 1994; 41: 679-84.
10 Nash JW, Hanson LA, StCyrCoats K. Detection of bovine immunodeficiency virus in blood and milk-derived leukocytes by use of polymerase chain reaction. Am J Vet Res 1995; 56: 445-9.
11 Nash JW, Hanson LA, StCyrCoats K. Bovine immunodeficiency virus in stud bull semen. Am J Vet Res 1995; 56: 760-3.
12 Polack B, Schwartz I, Berthelemy M, Belloc C, Manet G, Vuillaume A, Baron T, Gonda MA, Levy D. Serologic evidence for bovine immunodeficiency virus infection in France. Vet Microbiol 1996; 48: 165-73.
13 Scobie L, Venables C, Hughes K, Dawson M, Jarrett O. The antibody response of cattle infected with bovine immunodeficiency virus to peptides of the viral transmembrane protein. J Gen Virol 1999; 80: 237-43.
14 Scobie L, Venables C, Sayers AR, Weightman S, Jarrett O. Prevalence of bovine immunodeficiency virus infection in cattle in Great Britain. Vet Rec 2001; 149: 459-60.
15 Sellon RK, Jordan HL, Kennedy-Stoskopf S, Tompkins MB, Tompkins WA. Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol 1994; 68: 3380-5.
16 Snider TG, Hoyt PG, Jenny BF, Coats KS, Luther DG, Storts RW, Battles JK, Gonda MA. Natural and experimental bovine immunodeficiency virus infection in cattle. Vet Clin North Am Food Anim Pract 1997; 13: 151-76.
17 StCyrCoats K, Pruett SB, Nash JW, Cooper CR. Bovine immunodeficiency virus: incidence of infection in Mississippi dairy cattle. Vet Microbiol 1994; 42: 181-9.
18 VanDerMaaten MJ, Boothe AD, Deger CL. Isolation of a virus from cattle with persistent lymphocytosis. J Natl Canc Inst 1972; 49: 1649-57.